Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis
AR Maher, M Maglione, S Bagley, M Suttorp, JH Hu… - Jama, 2011 - jamanetwork.com
Context Atypical antipsychotic medications are commonly used for off-label conditions such
as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform …
as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform …
Weight gain and antipsychotics: a drug safety review
R Musil, M Obermeier, P Russ… - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Second-generation antipsychotics (SGAs) are widely used in several
psychiatric disease entities and exert to a different extent a risk for antipsychotic-induced …
psychiatric disease entities and exert to a different extent a risk for antipsychotic-induced …
[HTML][HTML] Almost all antipsychotics result in weight gain: a meta-analysis
M Bak, A Fransen, J Janssen, J van Os, M Drukker - PloS one, 2014 - journals.plos.org
Introduction Antipsychotics (AP) induce weight gain. However, reviews and meta-analyses
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …
[图书][B] The bitterest pills: The troubling story of antipsychotic drugs
J Moncrieff - 2013 - books.google.com
Page 1 Joanna Moncrieff Author of The Myth of º the Chemical Cure THE CBITTEREST The
Troubling Story of Antipsychotic Drugs * Page 2 The Bitterest Pills Page 3 Also by Joanna …
Troubling Story of Antipsychotic Drugs * Page 2 The Bitterest Pills Page 3 Also by Joanna …
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials
CY Lin, CH Chiang, MCM Tseng, KW Tam… - European …, 2023 - Elsevier
Quetiapine is a common off-label antipsychotic drug for treating insomnia. Its effects in
different disease conditions and dosages remain unclear. We conducted a systematic …
different disease conditions and dosages remain unclear. We conducted a systematic …
[HTML][HTML] Do atypical antipsychotics have antisuicidal effects? A hypothesis-generating overview
Modern antipsychotic drugs are employed increasingly in the treatment of mood disorders
as well as psychoses, stimulating interest in their possible contributions to altering suicidal …
as well as psychoses, stimulating interest in their possible contributions to altering suicidal …
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence
Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to
huge impacts on direct and indirect personal and public medical costs. To overcome such a …
huge impacts on direct and indirect personal and public medical costs. To overcome such a …
A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major …
M Bauer, N El-Khalili, C Datto, J Szamosi… - Journal of affective …, 2010 - Elsevier
BACKGROUND: Two positive studies evaluated adjunctive extended release quetiapine
fumarate (quetiapine XR) in patients with major depressive disorder (MDD) showing …
fumarate (quetiapine XR) in patients with major depressive disorder (MDD) showing …
[HTML][HTML] Second generation antipsychotics in the treatment of major depressive disorder: an update
SM Wang, C Han, SJ Lee, TY Jun… - Chonnam medical …, 2016 - synapse.koreamed.org
Less than one third of patients who suffer from major depressive disorder (MDD) report
remission following antidepressant treatments requiring more diverse treatment approaches …
remission following antidepressant treatments requiring more diverse treatment approaches …
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo …
M Liebowitz, RW Lam, U Lepola, C Datto… - Depression and …, 2010 - Wiley Online Library
Background: Primary objective: evaluate the efficacy (time to recurrence of depressive
symptoms) of once daily extended release quetiapine fumarate (quetiapine XR) as …
symptoms) of once daily extended release quetiapine fumarate (quetiapine XR) as …